The Medical and Scientific Team at Syndax Pharmaceuticals, Inc is responsible for overseeing the development and clinical evaluation of new combination therapies for cancer treatment. This includes conducting clinical trials, ensuring regulatory compliance, managing statistical analysis, and generating comprehensive medical documentation to support drug development and approval processes. The team collaborates closely to integrate scientific research with clinical expertise to advance Syndax’s product pipeline, particularly focusing on their lead candidate, entinostat.
Amanda Blaker
Director, Medical Writing
Angela Smith
Senior Medical Director
Christine Forbes-Dic...
Director, Systems Of Care - Ce...
Dennis O'Brien
Vice President, Head Of Drug S...
Derrick Z.
Principal Statistical Programm...
Elizabeth O'Connor
Executive Director, Head Of Me...
Jennifer Taing
Associate Director, Medical In...
Kate Madigan
Chief Medical Officer
Norman Nagl
Vice President, Medical Affair...
Peter Ordentlich
Chief Scientific Officer and F...